Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Article Commentary
Authors: Denner, Joachima; * | Tanzi, Rudolphb | Jacobson, Stevec
Affiliations: [a] Robert Koch Institute, Berlin, Germany | [b] Harvard University, Massachusetts General Hospital, Charlestown, MA, USA | [c] Viral Immunology, NINDS, NIH, Bethesda, MD, USA
Correspondence: [*] Correspondence to: Joachim Denner, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. Tel.: +49 30187542800; E-mail: [email protected].
Abstract: Animal models to study Alzheimer’s disease (AD) pathogenesis are under development. Since herpesviruses have been postulated to be capable of triggering the pathogenic process, AD animal models (mouse, pig, and non-human primates) should be controlled for the presence of these viruses. Only virus-free models allow studying the genetic factors and the effect of adding viruses. Roseoloviruses such as human herpesvirus 6 and the related viruses in the animals are the main topic of this commentary.
Keywords: Alzheimer’s disease, animal models, human herpesvirus 6, roseoloviruses
DOI: 10.3233/JAD-200591
Journal: Journal of Alzheimer's Disease, vol. 77, no. 2, pp. 543-545, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]